Federated Hermes’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,460
| Closed | -$21.1K | – | 2088 |
|
|
2026
Q1 | $21.1K | Buy |
1,460
+315
| +28% | +$4.51K | ﹤0.01% | 1770 |
|
|
2025
Q4 | $16.3K | Sell |
1,145
-667
| -37% | -$6.55K | ﹤0.01% | 1789 |
|
|
2025
Q3 | $14.3K | Buy |
+1,812
| New | +$12.9K | ﹤0.01% | 1847 |
|
|
2024
Q2 | – | Sell |
-28
| Closed | -$330 | – | 2056 |
|
|
2024
Q1 | $330 | Buy |
+28
| New | +$358 | ﹤0.01% | 1993 |
|
|
2023
Q4 | – | Sell |
-61
| Closed | -$742 | – | 2091 |
|
|
2023
Q3 | $742 | Sell |
61
-63
| -51% | -$813 | ﹤0.01% | 2021 |
|
|
2023
Q2 | $1.56K | Sell |
124
-109
| -47% | -$1.29K | ﹤0.01% | 2003 |
|
|
2023
Q1 | $2.58K | Buy |
+233
| New | +$2.87K | ﹤0.01% | 1987 |
|
|
2022
Q1 | – | Sell |
-227,192
| Closed | -$2.62M | – | 2233 |
|
|
2021
Q4 | $2.62M | Buy |
+227,192
| New | +$2.53M | ﹤0.01% | 982 |
|
|
2021
Q1 | – | Sell |
-388,812
| Closed | -$8.98M | – | 2266 |
|
|
2020
Q4 | $8.98M | Buy |
388,812
+243,047
| +167% | +$4.97M | 0.02% | 673 |
|
|
2020
Q3 | $2.06M | Buy |
145,765
+907
| +0.6% | +$13.2K | ﹤0.01% | 977 |
|
|
2020
Q2 | $2.18M | Buy |
+144,858
| New | +$1.77M | 0.01% | 966 |
|
|
2019
Q2 | – | Sell |
-872
| Closed | -$12K | – | 2173 |
|
|
2019
Q1 | $12K | Sell |
872
-77
| -8% | -$941 | ﹤0.01% | 1846 |
|
|
2018
Q4 | $9K | Sell |
949
-475
| -33% | -$5.22K | ﹤0.01% | 1887 |
|
|
2018
Q3 | $18K | Sell |
1,424
-96,607
| -99% | -$1.35M | ﹤0.01% | 1864 |
|
|
2018
Q2 | $1.53M | Buy |
98,031
+97,305
| +13,403% | +$1.47M | ﹤0.01% | 1130 |
|
|
2018
Q1 | $11K | Sell |
726
-64,195
| -99% | -$977K | ﹤0.01% | 1866 |
|
|
2017
Q4 | $934K | Sell |
64,921
-154,912
| -70% | -$2.13M | ﹤0.01% | 1241 |
|
|
2017
Q3 | $3.31M | Buy |
+219,833
| New | +$2.91M | 0.01% | 711 |
|
Other funds holding FOLD
Federated Hermes's FOLD Position: Q2 2026 in Review
Federated Hermes sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,460 shares — an estimated $21.1K sold.
Federated Hermes first reported a position in FOLD in Q3 2017 and held it in 18 quarters. The position peaked at $8.98M in Q4 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Federated Hermes reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Federated Hermes sold 1,460 Amicus Therapeutics shares in Q2 2026, an estimated $21.1K.
- Federated Hermes first reported a position in Amicus Therapeutics in Q3 2017 and held it in 18 quarters.
- Federated Hermes's Amicus Therapeutics position peaked at $8.98M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.